Table 1.
B1–1 | B2–5 | |||||
---|---|---|---|---|---|---|
N-glycans | *S1 | S2 | S3 | S1 | S2 | S3 |
GlcNAc(Xyl)Man3(Fuc)GlcNAc2 | 27.4 | 27.1 | 5.3 | 79.2 | 53.1 | 30.0 |
GlcNAc2(Xyl)Man3(Fuc)GlcNAc2 | 0.7 | 19.2 | 30.0 | 48.7 | ||
GalGlcNAc(Xyl)Man3(Fuc)GlcNAc2 | 72.6 | 35.9 | 21.5 | |||
Gal2GlcNAc2(Xyl)Man3(Fuc)GlcNAc2 | 5.1 | 13.5 | 6.2 | 4.0 | ||
GalGlcNAc(Xyl)Man3GlcNAc2 | 8.2 | 3.0 | ||||
GalGlcNAcMan3(Fuc)GlcNAc2 | 4.3 | |||||
GalGlcNAc2(Xyl)Man3(Fuc)GlcNAc2 | 2.0 | 10.7 | 9.5 | |||
†GlcNAc3(Xyl)Man3(Fuc)GlcNAc2 | 1.6 | 5.0 | ||||
‡(Fuc)GalGlcNAc(Xyl)Man3(Fuc)GlcNAc2 | 2.4 | |||||
¶PentGalGlcNAc(Xyl)Man3(Fuc)GlcNAc2 | 4.7 | 3.8 | ||||
Pent2GalGlcNAc(Xyl)Man3(Fuc)GlcNAc2 | 7.4 | 7.3 | ||||
Pent2Gal2GlcNAc2(Xyl)Man3(Fuc)GlcNAc2 | 3.2 | |||||
Pent3Gal2GlcNAc2(Xyl)Man3(Fuc)GlcNAc2 | 2.2 | |||||
§HexGalGlcNAc(Xyl)Man3(Fuc)GlcNAc2 | 2.2 | |||||
HexPentGalGlcNAc(Xyl)Man3(Fuc)GlcNAc2 | 1.4 | |||||
Hex1Pent2GalGlcNAc(Xyl)Man3(Fuc)GlcNAc2 | 2.9 | |||||
(Xyl)Man3(Fuc)GlcNAc2 | 2.8 | |||||
GlcNAc2(Xyl)Man3GlcNAc2 | 1.0 | |||||
Man5GlcNAc2 | 21.8 | |||||
Man6GlcNAc2 | 14.1 | |||||
Man7GlcNAc2 | 1.0 | |||||
Total (%) | 100 | 100 | 100 | 100 | 100 | 100 |
N-glycosylation site
N-glycan containing bisected GlcNAc
most probably Lewis A
N-glycan containing additional pentose
N-glycan containing additional hexose.